Clinical Trial Update: A Study to Test the Effects of Tolterodine Tartrate in Patients With Overactive Bladder (0000-107) [Phase 1]

View source ↗

Summary

Phase 1 trial assessing tolterodine tartrate for overactive bladder has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Tolterodine tartrate (Tolterodine tartrate)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Overactive Bladder | Phase 1 | Status: COMPLETED | Results posted: 2014-08-19